Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying some darker side effects in the long run? A new study shows these ...

Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...

A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being ...

A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting that these drugs could one day ...

When Bridgette Mitchell is struggling with her depression and needs a little boost, she knows what to do. She drives 20 minutes from her home in Tenafly to the Keta Medical Center in Oradell, sits in ...

Please provide your email address to receive an email when new articles are posted on . There is evidence that GLP-1s can ameliorate psychiatric and neurologic symptoms. More clinical trials on the ...

A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe ...

Addiction changes the brain, body, and behavior. Persistent insomnia, craving, depression, anhedonia, and anxiety may continue for months after sobriety, often leading to relapse. While we search for ...

Imagine unremitting despair, 24-7, minimally responsive or totally unresponsive to medication or therapy. Just endless depression. This is a problem for at least a third of adults with depression, ...